Syros Pharmaceuticals, Inc. (SYRS)
NASDAQ: SYRS · Real-Time Price · USD
2.430
+0.165 (7.28%)
Nov 4, 2024, 4:00 PM EST - Market closed

Syros Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Revenue
0.399.9414.8823.4915.091.98
Upgrade
Revenue Growth (YoY)
-95.61%-33.23%-36.65%55.62%661.50%-3.32%
Upgrade
Cost of Revenue
88.64108.15111.94---
Upgrade
Gross Profit
-88.25-98.22-97.0623.4915.091.98
Upgrade
Selling, General & Admin
23.2728.2829.323.0421.3321.48
Upgrade
Research & Development
---99.8776.0758.25
Upgrade
Operating Expenses
23.2728.2829.3122.9197.3979.72
Upgrade
Operating Income
-111.52-126.5-126.36-99.42-82.3-77.74
Upgrade
Interest Expense
-5.33-5.13-4.13-3.91-1.79-0.07
Upgrade
Interest & Investment Income
4.716.822.130.090.432.38
Upgrade
Other Non Operating Income (Expenses)
14.47-37.2833.7116.68-0.38-
Upgrade
EBT Excluding Unusual Items
-97.68-162.09-94.65-86.56-84.04-75.44
Upgrade
Merger & Restructuring Charges
-0.14-2.49----
Upgrade
Pretax Income
-97.82-164.57-94.65-86.56-84.04-75.44
Upgrade
Net Income
-97.82-164.57-94.65-86.56-84.04-75.44
Upgrade
Net Income to Common
-97.82-164.57-94.65-86.56-84.04-75.44
Upgrade
Shares Outstanding (Basic)
372813654
Upgrade
Shares Outstanding (Diluted)
372813654
Upgrade
Shares Change (YoY)
31.77%124.24%102.00%35.79%14.49%23.17%
Upgrade
EPS (Basic)
-2.66-5.81-7.49-13.84-18.25-18.76
Upgrade
EPS (Diluted)
-2.66-5.81-7.49-13.84-18.25-18.76
Upgrade
Free Cash Flow
-100.05-109.98-124.31-100.79-60.7-72.89
Upgrade
Free Cash Flow Per Share
-2.72-3.88-9.84-16.12-13.18-18.12
Upgrade
Gross Margin
---100.00%100.00%100.00%
Upgrade
Operating Margin
-28891.71%-1273.14%-849.21%-423.28%-545.27%-3922.35%
Upgrade
Profit Margin
-25340.67%-1656.34%-636.12%-368.52%-556.80%-3806.16%
Upgrade
Free Cash Flow Margin
-25920.73%-1106.87%-835.39%-429.09%-402.17%-3677.65%
Upgrade
EBITDA
-110.18-124.25-123.66-96.4-79.26-75.02
Upgrade
D&A For EBITDA
1.342.252.713.023.042.72
Upgrade
EBIT
-111.52-126.5-126.36-99.42-82.3-77.74
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.